RLWM
RVNC
RF&L Wealth Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-48,000
| Closed | -$146K | – | 60 |
|
|
2024
Q4 | $146K | Hold |
48,000
| – | – | 0.1% | 57 |
|
|
2024
Q3 | $249K | Hold |
48,000
| – | – | 0.18% | 54 |
|
|
2024
Q2 | $123K | Buy |
48,000
+15,000
| +45% | +$38.6K | 0.09% | 56 |
|
|
2024
Q1 | $162K | Hold |
33,000
| – | – | 0.13% | 56 |
|
|
2023
Q4 | $290K | Buy |
33,000
+5,000
| +18% | +$44K | 0.24% | 49 |
|
|
2023
Q3 | $321K | Buy |
28,000
+8,000
| +40% | +$91.8K | 0.3% | 43 |
|
|
2023
Q2 | $506K | Hold |
20,000
| – | – | 0.46% | 36 |
|
|
2023
Q1 | $644K | Buy |
+20,000
| New | +$644K | 0.62% | 34 |
|